Download
s40658-021-00385-4.pdf 1,24MB
WeightNameValue
1000 Titel
  • Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
1000 Autor/in
  1. Rosar, Florian |
  2. Schön, Niklas |
  3. Bohnenberger, Hendrik |
  4. Bartholomä, Mark |
  5. Stemler, Tobias |
  6. Maus, Stephan |
  7. Khreish, Fadi |
  8. Ezziddin, Samer |
  9. Schaefer-Schuler, Andrea |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-05-05
1000 Erschienen in
1000 Quellenangabe
  • 8(1):40
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40658-021-00385-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099965/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Dosimetry is of high importance for optimization of patient-individual PSMA-targeted radioligand therapy (PSMA-RLT). The aim of our study was to evaluate and compare the feasibility of different approaches of image-based absorbed dose estimation in terms of accuracy and effort in clinical routine.!##!Methods!#!Whole-body planar images and SPECT/CT images were acquired from 24 patients and 65 cycles at 24h, 48h, and ≥96h after administration of a mean activity of 6.4 GBq [!##!Results!#!Mean absorbed doses estimated by 3D dosimetry (the reference method) were 0.54 ± 0.28 Gy/GBq for the kidneys, 0.10 ± 0.05 Gy/GBq for the liver, 0.81 ± 0.34 Gy/GBq for the parotid gland, 0.72 ± 0.39 Gy/GBq for the submandibular gland, and 1.68 ± 1.32 Gy/GBq for bone metastases. Absorbed doses of normal organs estimated by hybrid dosimetry showed small, non-significant differences (median up to 4.0%) to the results of 3D dosimetry. Using 2D dosimetry, in contrast, significant differences (median up to 10.9%) were observed. Regarding bone metastases, small, but significant differences (median up to 7.0%) of absorbed dose were found for both, 2D dosimetry and hybrid dosimetry. Bland-Altman analysis revealed high agreement between hybrid dosimetry and 3D dosimetry for normal organs and bone metastases, but substantial differences between 2D dosimetry and 3D dosimetry.!##!Conclusion!#!Hybrid dosimetry provides high accuracy in estimation of absorbed dose in comparison to 3D dosimetry for all important organs and is therefore feasible for use in individualized PSMA-RLT.
1000 Sacherschließung
lokal Radioligand therapy
lokal Hybrid
lokal Original Research
lokal PSMA
lokal Dosimetry
lokal Prostate cancer
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Um9zYXIsIEZsb3JpYW4=|https://frl.publisso.de/adhoc/uri/U2Now7ZuLCBOaWtsYXM=|https://frl.publisso.de/adhoc/uri/Qm9obmVuYmVyZ2VyLCBIZW5kcmlr|https://frl.publisso.de/adhoc/uri/QmFydGhvbG9tw6QsIE1hcms=|https://frl.publisso.de/adhoc/uri/U3RlbWxlciwgVG9iaWFz|https://frl.publisso.de/adhoc/uri/TWF1cywgU3RlcGhhbg==|https://frl.publisso.de/adhoc/uri/S2hyZWlzaCwgRmFkaQ==|https://frl.publisso.de/adhoc/uri/RXp6aWRkaW4sIFNhbWVy|https://orcid.org/0000-0002-2439-5786
1000 Hinweis
  • DeepGreen-ID: 45f55e7d647e4b959736b7960ed1f356 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6442082.rdf
1000 Erstellt am 2023-04-26T13:00:56.506+0200
1000 Erstellt von 322
1000 beschreibt frl:6442082
1000 Zuletzt bearbeitet Thu Oct 19 11:45:31 CEST 2023
1000 Objekt bearb. Thu Oct 19 11:45:31 CEST 2023
1000 Vgl. frl:6442082
1000 Oai Id
  1. oai:frl.publisso.de:frl:6442082 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source